The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
news-avastin
Friday 19 April 2013
Target Ovarian Cancer is disappointed in the decision by the National Institute for Health and Care Excellence to reject the use of Avastin (Bevacizumab) together with Gemcitabine and Carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer in England and Wales....
News
news-avastin
Friday 5 April 2013
Following recent knockbacks from the National Institute for Health and Care Excellence we are pleased to confirm that Avastin for the first line treatment of women with advanced ovarian cancer will be available through the English Cancer Drugs Fund until the end of this year, in a simplified...
News
Monday 25 March 2013
The National Institute for Health and Care Excellence (NICE) has published today a negative final recommendation (FAD) for the use of Avastin (bevacizumab) in combination with paclitaxel and carboplatin for women with newly-diagnosed advanced ovarian cancer. Target Ovarian Cancer is deeply...
News
Friday 1 February 2013
New draft guidance issued by the National Institute for Health and Clinical Excellence (NICE) means that Avastin will not be available on the NHS in cases where advanced ovarian cancer has returned at least six months after the woman has undergone platinum-based chemotherapy. It has said it is 'not...

Pages